Pharmacogenetic evidence that Cd36 is a key determinant of the metabolic effects of pioglitazone | Charles Explorer

Pharmacogenetic evidence that Cd36 is a key determinant of the metabolic effects of pioglitazone

Publikace na 1. lékařská fakulta |

2002

Abstrakt

Genetic, pharmacogenetic

Osoby